MS-553, a Selective PKC-ß Inhibitor Inhibits BCR Signaling and Synergizes with Venetoclax for the Treatment of High Risk CLL
| Autor: | Singh, Jyotsana 1, *, Diaz Rohena, Daisy 1, *, Liu, Chaomei 1, *, Slawin, Bailey 1, *, Ravikrishnan, Janani 2, Jain, Nitin 3, Wierda, William G. 4, Zhang, Kai 5, *, Niesman, Michael 5, *, Woyach, Jennifer A. 2, Sampath, Deepa 1 |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:9857-9858 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|